A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

Patents for A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
11/2001
11/15/2001	DE10113324A1 A combined plant coagulate composition, process for the manufacture thereof and uses thereof
11/15/2001	DE10022801A1 Well tolerated natural medicament for treating urological, gynecological or intestinal diseases, comprising black caraway oil, tea tree oil and grapefruit seed extract.
11/15/2001	CA2408889A1 Immunosuppressive compositions
11/15/2001	CA2408544A1 Combined marine and plant extract compositions
11/15/2001	CA2408220A1 Antitubulin assembly and cell growth inhibitor denominated "dioxostatin"
11/15/2001	CA2408112A1 Skin protectant spray compositions
11/15/2001	CA2407743A1 Irradiation of ispaghula
11/15/2001	CA2407712A1 Use of echinacea as a hematinic agent
11/15/2001	CA2406558A1 Antimicrobial composition formulated with essential oils
11/14/2001	EP1153605A1 Proanthocyanidins and ascorbic acid composition for topical application to human respiratory and oral mucosa
11/14/2001	EP1153604A1 Adp-ribosylation inhibitors and remedies for endotoxic bacterial enteric infection containing proanthocyanidin as the active ingredient
11/14/2001	EP1153033A1 Method for purifying a red fruit extract containing anthocyanosides
11/14/2001	EP1152731A1 A skin care composition that mediates cell to cell communication
11/14/2001	EP1024818B1 Natural color concentrates and antimicrobial nutraceutical from plants
11/14/2001	EP1003537B1 Composition comprising propolis and at least an essential oil
11/14/2001	EP0980250B1 Plant extracts for the treatment of increased bone resorption
11/14/2001	EP0760648B1 Chewable flubendazole tablets for companion animals
11/14/2001	CN1322209A Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor
11/14/2001	CN1322132A Bioflavonoid as blood gloucose level lowering agent
11/14/2001	CN1322111A Natural tea for curing men's impotence and method for manufacturing the same
11/14/2001	CN1321500A Method for preventing and curing diseases by using kakonein preparation
11/14/2001	CN1321444A Composition contg. anthocyanidin
11/13/2001	US6316499 Administering formulation comprising asubstance or substances selected from synephrine, hordenine, synephrine, hordenine, octopamine, tyramine and n-methyltyramine for increasing muscle mass of human
11/13/2001	US6316032 Dipping barley spent grains in a polar organic solvent; separating dipping solution into an extract liquid and a residue; concentrating said extract liquid; and recovering the concentrate of barley malt oil
11/13/2001	US6316002 Germination activated red Ganoderma lucidum spores and method for producing the same
11/13/2001	US6316001 Method for treatment of psoriasis
11/11/2001	CA2347301A1 Proanthocyanidins and ascorbic acid composition for topical application to human respiratory and oral mucosa
11/08/2001	WO2001083704A1 Spray-dried microbial cells
11/08/2001	WO2001083385A2 Devices and method for production of traceable immunizing drinking water, other liquids and gas
11/08/2001	WO2001083031A2 Topical composition for the treatment of psoriasis and related skin disorders
11/08/2001	WO2001082941A1 Composition for treatment of b-type hepatitis and liver cirrhosis
11/08/2001	WO2001082940A1 Plant extract of the olea europaea species as no-synthase inhibitor and uses
11/08/2001	WO2001082935A1 Remedies for cancer
11/08/2001	WO2001082887A1 Plant extract of the species vitis vinifera as no-synthase inhibitor and uses
11/08/2001	WO2001082885A1 Cosmetic and/or pharmaceutical preparations that contain an extract of the plant argania spinosa
11/08/2001	WO2001082859A2 Method for producing r-teatrol analogs having an antineoplastic activity
11/08/2001	WO2001082719A1 Process for enhancing immune response in canines using a dietary composition including garlic
11/08/2001	WO2001028325A3 Compositions including reduced malto-oligosaccharide preserving agents
11/08/2001	US20010039296 Method and composition for preventing or reducing the symptoms of menopause
11/08/2001	US20010038863 Modifying the effect of a first drug by adding a second drug; soporific agent and a stimulant for example
11/08/2001	DE10118999A1 Treating or preventing male climacteric disorders, e.g. depression, using combination of plant components having estrogen-like action and psycho-vegetative agents and/or antioxidants
11/08/2001	CA2407614A1 Dried microorganism cell product by spray-drying
11/08/2001	CA2407314A1 Process for enhancing immune response in canines using a dietary composition including garlic
11/08/2001	CA2407311A1 Plant extract of the species vitis vinifera as no-synthase inhibitor and uses
11/08/2001	CA2407294A1 Plant extract of the olea europaea species as no-synthase inhibitor and uses
11/07/2001	EP1151745A1 Water-in-oil emulsion and its use in cosmetics
11/07/2001	EP1151292A1 Process for quality control and standardisation of medicinal plant products
11/07/2001	EP1151129A2 Methods of making compounds
11/07/2001	EP1150697A1 High molecular weight extracts of convolvulus arvensis (field bindweed)
11/07/2001	EP1150695A2 Herbal supplement for increased muscle strength and endurance for athletes
11/07/2001	EP1150669A1 L-arginine based formulations for treating diseases and methods of using same
11/07/2001	EP1150652A1 Skin lightening agents
11/07/2001	EP1150577A1 Improved microbial preparations
11/07/2001	EP1150574A1 A natural tea for curing men's impotence and a method for manufacturing the same
11/07/2001	EP1089620A4 Hydrophilic polymer blends used to prevent cow skin infections
11/07/2001	EP0949901B1 Cosmetic cleansing and skin care preparation containing plant and algae extracts
11/07/2001	EP0769917B1 Nervonic acid compositions
11/06/2001	US6313214 Melanin inhibiting and cell growth activating compositions containing compounds having labdane structure
11/06/2001	US6313103 Pectic substance as a growth factor stabilizer
11/06/2001	US6312753 Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses
11/06/2001	US6312738 Azadirachtin extraction process
11/06/2001	US6312737 The cancer cells can be leukemia cells and prostate cancer cells.
11/06/2001	US6312736 That can be applied sublingually for rapid, effective pain relief.
11/06/2001	US6312730 Gum acacia, mixing powdered psyllium husks and drying
11/06/2001	US6312709 Seaweed supplement diet for enhancing immune response in mammals and poultry
11/06/2001	US6312698 Anti-fungal formulation active against a broad spectrum of dermatophytoses
11/06/2001	US6312697 Inhibitory effect of synthetic and natural colorants on carcinogenesis
11/06/2001	US6312675 Shampoo with plant extracts
11/01/2001	WO2001080937A1 Drug delivery device for insertion in the vagina, rectum or nasal cavity
11/01/2001	WO2001080870A2 Compositions derived from cranberry and grapefruit and therapeutic uses therefor
11/01/2001	WO2001080869A1 Minari extract for preventing the induction and metastasis of cancer by carcinogens contained in cigarette smoke, fermented foods or alcoholic drinks
11/01/2001	WO2001080868A1 Novel medicines based on sesquiterpene mixtures
11/01/2001	WO2001080829A2 Taste masking coating composition
11/01/2001	WO2001028356A3 Food supplement for increasing lean mass and strength
11/01/2001	WO2001026457A3 Non-toxic aqueous pesticide
11/01/2001	WO2000066111A9 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/01/2001	US20010036943 Mixture of analgesic and carrier
11/01/2001	US20010036489 Anti-wrinkle preparation and method of reducing wrinkles in facial skin and neck
11/01/2001	US20010036488 Eucalyptus extract as active ingredient and biologically acceptable carrier or diluent; treatment of lipid storage disease, hyperlipemia, arteriosclerosis, or thrombosis; anticholesterol agent
11/01/2001	US20010036487 Proanthocyanidin-containing composition
11/01/2001	US20010036486 Administering to subject a therapeutically effective amount of Hypericum perforatum or active component thereof
11/01/2001	US20010036485 Orally administered St.John's Wort-based herbal supercritical extract comprising highly stable hyperforins
11/01/2001	US20010036484 Improving blood flow circulation by administration of the combination of medicinal plants Panax ginseng and Ginkgo biloba or extracts thereof
11/01/2001	CA2407442A1 Novel medicines based on sesquiterpene mixtures
11/01/2001	CA2405348A1 Novel compositions derived from cranberry and grapefruit and therapeutic uses therefor
10/2001
10/31/2001	EP1149578A1 Cosmetic or pharmaceutical compositions containing an Argania Spinosa extract
10/31/2001	EP0869806B1 A pharmaceutical composition comprising plant worms and muirapuama
10/31/2001	EP0627918B1 New use of omega-3-fatty acids
10/31/2001	DE10019670A1 Medicament containing red pepper constituents useful as a dermatological agent, especially for treatment of damaged skin
10/31/2001	CN1319431A Method for improving antitumor activity of amarogentin substance and its composition and evaluation method
10/30/2001	US6309687 Anti-first-pass effect compounds
10/30/2001	US6309678 Process for isolation of hepatoprotective agent silymarin from the seeds of the plant Silybum marianum
10/30/2001	US6309677 Mixture of algal extract containing alpha and beta carotene, plam fruit extract containing alpha and beta carotene and a marigold flower extract containing lutein
10/30/2001	US6309676 Raw garlic bonded to surface of chewable object
10/30/2001	US6309675 Therapeutic composition including plantain and aloe vera for treatment of arthritis and other afflictions
10/30/2001	US6309674 Administering smilax china, or similiar plant extract
10/30/2001	CA2025113C Agent for preventing infection with antibiotic-resistant staphylococcus
10/25/2001	WO2001078704A2 Gaba substrate and the use thereof for treating cognitive and emotional disorders
10/25/2001	WO2001078701A2 Method and compositions for preventing hormone induced adverse effects
10/25/2001	WO2001078675A1 Use of natural substances in the production of cosmetic preparations

1 ... 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 ... 1794